Viewing Study NCT05088967

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 12:32 AM

Ignite Modification Date: 2025-12-31 @ 6:08 PM

Study NCT ID: NCT05088967

Status: TERMINATED

Last Update Posted: 2024-01-16

First Post: 2021-09-28

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Efficacy and Safety of IBI110 in Combination With Sintilimab Versus Sintilimab Alone in Neoadjuvant and Adjuvant Therapy of Radically Resectable Non-small Cell Lung Cancer

Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module